Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
11.12
-0.26 (-2.28%)
At close: Jun 18, 2025, 4:00 PM
11.11
-0.01 (-0.08%)
After-hours: Jun 18, 2025, 7:58 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $993.15 million as of June 18, 2025. Its market cap has increased by 125.30% in one year.
Market Cap
993.15M
Enterprise Value
564.71M
1-Year Change
125.30%
Ranking
Category
Stock Price
$11.12
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has increased from $869.34M to $993.15M, an increase of 14.24%. That is a compound annual growth rate of 3.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 993.15M | 107.99% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |